AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Yi-Long Wu

Yi-Long Wu

Guangdong Provincial People's Hospital - Guangzhou / China
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4687421
广东省人民医院
person_outline Yi-Long Wu's MOST POPULAR ARTICLES
1-) Gefitinib or carboplatin–paclitaxel in pulmonary adenocarcinoma New England Journal of Medicine 361 (10), 947-957, 2009
2-) Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open … The lancet oncology 12 (8), 735-742, 2011
3-) The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer Journal of Thoracic Oncology 11 (1), 39-51, 2016
4-) Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer New England Journal of Medicine 368 (25), 2385-2394, 2013
5-) First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer New England Journal of Medicine 371 (23), 2167-2177, 2014